Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

12 results about "Staphylococcus aureus enterotoxin" patented technology

Staphylococcus aureus Enterotoxins. The S. aureus enterotoxins (SEs) are potent gastrointestinal exotoxins synthesized by S. aureus throughout the logarithmic phase of growth or during the transition from the exponential to the stationary phase [16,17,18,19,20].

A nanoantibody for detecting Staphylococcus aureus enterotoxin B and its application

ActiveCN119978118BAntibacterial agentsImmunoglobulins against bacteriaStaphylococcus aureus enterotoxin BAntigen testing
The present invention relates to the field of antigen detection technology, and in particular to a nanobody for detecting Staphylococcus aureus enterotoxin B and its application. The nanobody comprises an amino acid sequence as shown in SEQ ID NO.1 or SEQ ID NO.2. The applications include: purification, detection, and removal of Staphylococcus aureus enterotoxin B. The present invention screened and obtained two nanobodies for SEB, which have high specificity and high affinity for SEB. Detection of SEB based on these two nanobodies has high specificity and sensitivity, which is of great value in the field of Staphylococcus aureus enterotoxin detection.
Owner:ICDC CHINA CDC

Nanometer antibody for detecting staphylococcus aureus enterotoxin B and application thereof

ActiveCN119978118AAntibacterial agentsImmunoglobulins against bacteriaStaphylococcus aureus enterotoxin BAntigen testing
The invention relates to the technical field of antigen detection, in particular to a nano antibody for detecting staphylococcus aureus enterotoxin B and application of the nano antibody. The nano antibody comprises an amino acid sequence as shown in SEQ ID NO. 1 or SEQ ID NO. 2. The application comprises purification, detection and removal of the staphylococcus aureus enterotoxin B. The two SEB nanometer antibodies obtained through screening have high specificity and high affinity with the SEB, SEB detection based on the two nanometer antibodies has high specificity and sensitivity, and the SEB nanometer antibodies have important value in the field of staphylococcus aureus enterotoxin detection.
Owner:ICDC CHINA CDC

Nanobodies, antibody compositions and applications thereof for detecting Staphylococcus aureus enterotoxin H

ActiveCN119954946BImmunoglobulins against bacteriaFermentationImmunological testingDisease
This invention belongs to the field of immunological testing and discloses nanobodies, antibody compositions, and their applications for detecting Staphylococcus aureus enterotoxin H. The invention successfully screened for Staphylococcus aureus enterotoxin H-specific antibodies and used a checkerboard titration method to identify capture antibodies, AntiSEH-Nb4, and detection antibodies, AntiSEH-Nb3. The resulting antibodies are effective for detecting food poisoning caused by non-classical enterotoxin H, providing a highly specific means of detecting Staphylococcus aureus enterotoxin H. This not only improves the accuracy and reliability of detection but also facilitates the rapid diagnosis and prevention of outbreaks of related foodborne diseases.
Owner:ICDC CHINA CDC

Staphylococcus aureus nanocrystallization antigen, vaccine containing staphylococcus aureus nanocrystallization antigen and application of staphylococcus aureus nanocrystallization antigen

The invention provides a staphylococcus aureus nanocrystallization antigen, a vaccine containing the staphylococcus aureus nanocrystallization antigen and application of the staphylococcus aureus nanocrystallization antigen. The staphylococcus aureus nanocrystallization antigen is obtained by modifying a staphylococcus aureus antigen through a nanocrystallization matrix, and the nanocrystallization matrix is one or more of streptococcus pneumoniae capsular polysaccharide, staphylococcus aureus capsular polysaccharide and sodium hyaluronate; the staphylococcus aureus antigen is one or more of staphylococcus aureus enterotoxin A, staphylococcus aureus enterotoxin B, staphylococcus aureus enterotoxin C2 and toxic shock toxin syndrome toxin 1. The staphylococcus aureus nanocrystallization antigen and the vaccine containing the staphylococcus aureus nanocrystallization antigen can induce high-level immune response, the antibody durability is high, the dosage of the used antigen is low, and the safety is good; and the preparation method is simple, high in production efficiency and low in cost.
Owner:JIANGSU KUNLI BIOPHARMACEUTICAL CO LTD

Photoelectrochemical immunosensor based on dendritic peptide tetramer as well as preparation method and application of photoelectrochemical immunosensor

PendingCN121978183AMaterial analysis by electric/magnetic meansBiological testingPhotocathodeStaphylococcus aureus enterotoxin
The invention belongs to the technical field of biosensors, and discloses a photoelectrochemical immunosensor based on a dendritic peptide tetramer as well as a preparation method and application of the photoelectrochemical immunosensor. The dendritic peptide tetramer is adopted to construct the photoelectrochemical immunosensor for the first time, and the method comprises the following steps: preparing an HsGDY / Cu2O photocathode, and sequentially anchoring an antibody probe and the dendritic peptide tetramer on the surface of the photocathode. Through specific binding of a target object and the antibody probe, a significant steric hindrance effect is generated on an electrode interface, interface charge transfer is hindered, photocurrent signal change is caused, and detection of the target object staphylococcus aureus enterotoxin A is realized. The photoelectrochemical immunosensor provided by the invention is simple, convenient and efficient in preparation process, has excellent food matrix biological pollution resistance, can effectively inhibit non-specific adsorption so as to significantly improve the sensitivity, specificity and accuracy of detection, is suitable for the field of food safety detection, and is suitable for market popularization and application.
Owner:QINGDAO UNIV OF SCI & TECH

Label-free proportional staphylococcus aureus enterotoxin A luminous aptamer biosensor

The invention discloses a label-free proportional type luminous aptamer biosensor for staphylococcus aureus enterotoxin A (SEA). The label-free proportional type luminous aptamer biosensor comprises the following steps: (1) advanced evolution screening of a complex matrix high-adaptability aptamer; (2) rationally cutting the aptamer assisted by computer simulation; (3) a construction strategy of the label-free proportional biosensor; (4) a label-free proportional SEA bifunctional biosensor sequence; (5) optimizing conditions of the label-free proportional SEA biosensor; and (6) SEA detection. The design principle is that fluorescence of SEA and ThT is excited to different degrees on the basis of a competitive binding effect between an SEA target and a small molecule nucleic acid dye thioflavin T (ThT) as well as a luminous nucleic acid aptamer, so that the ratio of fluorescence signals of the SEA and the ThT is in a linear relationship with the target concentration, and finally, rapid, label-free and low-cost proportional fluorescence detection of the SEA is realized.
Owner:CHINA AGRI UNIV

High-throughput staphylococcus aureus enterotoxin microfluidic chip detection method based on chain amplification and enhanced fluorescence and application

The present application relates to a kind of high-throughput staphylococcus aureus enterotoxin microfluidic chip detection method and application based on chain quantity amplification enhanced fluorescence.The microfluidic chip is provided with fluorescence sensor, and the fluorescence sensor includes identification probe and signal probe;The identification probe is composed of magnetic nanoparticle, nucleic acid aptamer H1 of target to be measured and target aptamer complementary chain H2, and the signal probe is composed of nanomaterial with signal amplification function and three oligonucleotides H3, H4, H5.The present application combines MNPs-ssDNA-AuNPs sandwich structure system and microfluidic chip, realizes detection signal amplification using the excellent superparamagnetic property of MNPs and the high loading capacity of AuNPs, constructs high-throughput, high-sensitivity fluorescence sensing technology for SEA, SEB and SEC1 detection, simplifies experimental process, and builds the rapid, efficient detection platform of multiple pollutants in food.
Owner:ACADEMY OF MILITARY MEDICAL SCIENCES

Universal purification method of recombinant staphylococcus aureus protein antigen

PendingCN121005760APeptide preparation methodsDepsipeptidesStaphylococcal EnterotoxinsStaphylococcus aureus enterotoxin
The invention provides a universal purification method of a recombinant staphylococcus aureus protein antigen. The purification method comprises the steps of sample treatment and refined purification. Wherein the sample treatment comprises fermentation material liquid crushing, crushed sample clarification and clarified sample concentration; the fine purification comprises primary purification, medium purification and fine purification; the recombinant staphylococcus aureus protein antigen is recombinant staphylococcus aureus enterotoxin A, enterotoxin B, enterotoxin C2 and / or toxic shock syndrome toxin 1. The purification method meets the quality standard required by pharmacopeia, also has the advantages of high yield, simple process, easy amplification and low cost, and greatly simplifies the production and preparation work of the recombinant staphylococcus aureus enterotoxin A, enterotoxin B, enterotoxin C2 and toxic shock syndrome toxin 1.
Owner:JIANGSU KUNLI BIOPHARMACEUTICAL CO LTD

Application of Curcumin-Mediated Photodynamic Degradation of Staphylococcal Enterotoxin

The present invention discloses an application of curcumin-mediated photodynamic degradation of Staphylococcus aureus enterotoxin. The present invention effectively proves through experiments that water-soluble curcumin-mediated photodynamic can effectively reduce the enterotoxin content and its immunological activity. The present invention also provides a method for effectively inactivating Staphylococcus aureus and its enterotoxin. This method has high safety, low equipment requirements, simple operation, causes non-specific damage to the bacteria, is not prone to generating resistance, is non-toxic, has low cost, and can effectively control the risk of food poisoning caused by Staphylococcus aureus and its enterotoxin. The water-soluble curcumin-mediated photodynamic technology provided by the present invention has the potential for application in food processing.
Owner:JINAN UNIVERSITY

Active super-antigen compound biological injection preparation G for treating muscle and bone joint diseases and preparation method of active super-antigen compound biological injection preparation G

The invention relates to the technical field of biological pharmacy, and discloses an active super antigen compound biological injection preparation G for treating muscle and joint diseases. The preparation comprises the following components in percentage by mass: 18%-28% of the super antigen compound, 35%-45% of the amino acid mixture and 12%-18% of the bioactive nanoparticle carrier, wherein the super antigen compound accounts for 18%-28% of the total mass of the preparation; the amino acid mixture accounts for 35%-45% of the total mass of the preparation; and the bioactive nanoparticle carrier accounts for 12%-18% of the total mass of the preparation. According to the active super antigen compound biological injection preparation G for treating the muscle and bone joint diseases and the preparation method, a super antigen compound comprises a staphylococcus aureus enterotoxin variant modified by gene engineering and a recombinant human interleukin-1 receptor antagonist fusion protein, and inflammation is reduced without damaging cartilage by precisely regulating and controlling immune response; l-homocysteine and L-hydroxyproline in the amino acid mixture have a synergistic effect, so that not only can free radicals be eliminated, but also cartilage repair and regeneration can be promoted, the problem of cartilage degeneration caused by long-term use of a traditional medicine is effectively solved, and the self-repair capability of tissues is improved.
Owner:林波

A biosensor and electrochemical detection method for detecting staphylococcus aureus enterotoxin a

PendingCN122361561ABiotechnologyStaphylococcus aureus enterotoxin
This invention discloses a biosensor and electrochemical detection method for detecting Staphylococcus aureus enterotoxin A (SEA). The biosensor includes an electrode modified with an MXene / AuNPs nanocomposite material, a recognition probe complex, a signal probe complex, and a capture probe. This invention increases the electrode's conductivity and specific surface area by modifying the electrode surface with the MXene / AuNPs complex. Simultaneously, it introduces a chain substitution reaction signal amplification strategy, achieving efficient amplification of the electrochemical signal and significantly improving detection sensitivity. This sensor combines the excellent properties of nanomaterials with a nucleic acid signal amplification strategy, exhibiting good specificity, stability, and repeatability in SEA detection. Furthermore, this sensor requires no complex pretreatment, has a rapid response, and shows great potential for detection in practical food samples.
Owner:NANJING FORESTRY UNIV

Bifidobacterium bifidum and its application in improving asthma and histamine intolerance

ActiveCN119144528BBacteriaAntinoxious agentsHistamine intoleranceStaphylococcus aureus enterotoxin
The present invention discloses Bifidobacterium bifidum and its application in improving asthma and histamine intolerance, belonging to the technical field of marine microorganisms. Bifidobacterium bifidum ) NHNK‑618, which was deposited in the China Center for Type Culture Collection on August 9, 2024, and its deposit number is CCTCCNO: M20241761. NHNK‑618 has the functions of regulating asthma-related flora, agglutinating asthma-related pathogens, reducing Staphylococcus aureus enterotoxin, reducing bronchial histamine receptor activation, promoting bronchial barrier integrity, reducing airway remodeling, and degrading histamine. In addition, NHNK‑618 bacterial biofilm can increase the colonization ability of intestinal epithelial cells. It can be used to prepare products that improve asthma and histamine intolerance.
Owner:QINGDAO NOVO NUOKANG BIOTECHNOLOGY CO LTD